Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001121404-24-000003
Filing Date
2024-02-01
Accepted
2024-02-01 09:45:14
Documents
5
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 6-K a6kcoverpagepressreleaseq4.htm 6-K 13005
2 EX-99.1 pressreleaseq42023english.htm EX-99.1 993134
3 GRAPHIC capturedecran2024-01x23a18a.jpg GRAPHIC 141944
4 GRAPHIC chart-22b986bd4a964014b65a.jpg GRAPHIC 78242
5 imagea.jpg GRAPHIC 4047
  Complete submission text file 0001121404-24-000003.txt   1316548
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 24585281
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)